Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6599
-0.0202 (-2.97%)
At close: May 30, 2025, 4:00 PM
0.6700
+0.0101 (1.53%)
After-hours: May 30, 2025, 7:59 PM EDT

Immunic Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Selling, General & Admin
18.1518.0116.0115.2613.310.33
Upgrade
Research & Development
82.8480.0583.2271.2661.1238.64
Upgrade
Operating Expenses
10198.0599.2286.5274.4248.97
Upgrade
Operating Income
-101-98.05-99.22-86.52-74.42-48.97
Upgrade
Interest & Investment Income
2.393.393.081.040.070.06
Upgrade
Currency Exchange Gain (Loss)
-----2.5
Upgrade
Other Non Operating Income (Expenses)
2.21-1.052.54-1.96-1.352.4
Upgrade
EBT Excluding Unusual Items
-96.4-95.71-93.61-87.44-75.7-44.02
Upgrade
Impairment of Goodwill
----32.97--
Upgrade
Asset Writedown
--4.8----
Upgrade
Other Unusual Items
-----17.25-
Upgrade
Pretax Income
-96.4-100.51-93.61-120.41-92.95-44.02
Upgrade
Net Income
-96.4-100.51-93.61-120.41-92.95-44.02
Upgrade
Net Income to Common
-96.4-100.51-93.61-120.41-92.95-44.02
Upgrade
Shares Outstanding (Basic)
10110044322416
Upgrade
Shares Outstanding (Diluted)
10110044322416
Upgrade
Shares Change (YoY)
75.28%126.03%39.29%34.52%51.00%102.84%
Upgrade
EPS (Basic)
-0.95-1.00-2.11-3.78-3.93-2.81
Upgrade
EPS (Diluted)
-0.96-1.00-2.11-3.78-3.93-2.81
Upgrade
Free Cash Flow
-82.85-85.03-71.16-65.26-83.3-46.27
Upgrade
Free Cash Flow Per Share
-0.82-0.85-1.61-2.05-3.52-2.95
Upgrade
EBITDA
-100.85-97.92-99.11-86.44-74.33-48.93
Upgrade
D&A For EBITDA
0.150.130.110.080.090.04
Upgrade
EBIT
-101-98.05-99.22-86.52-74.42-48.97
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q